Cure for cancer? UK scientists are creating a vaccine that could stop disease up to 20 years early
Pharmaceutical giant GSK and the University of Oxford are collaborating on developing a cancer vaccine that aims to detect pre-cancer cells up to 20 years before they become malignant. This innovative approach leverages advances in technology to create targeted immunizations against early-stage cancer development.
Pharmaceutical giant GSK and the University of Oxford are collaborating on developing a cancer vaccine that aims to detect pre-cancer cells up to 20 years before they become malignant. This innovative approach leverages advances in technology to create targeted immunizations against early-stage cancer development.
